AI-powered • Security operations
ReliaQuest is an AI-powered security operations company that offers the GreyMatter platform to integrate with cybersecurity tools for enhanced threat detection and response.
Healthtech • Alfapump system
Sequana Medical develops and commercializes the alfapump system, a medical device for managing fluid overload in patients, and is advancing its Direct Sodium Removal therapy.
Business travel management • Expense management
TravelPerk is a business travel management platform that integrates travel and expense management into a single solution.
Gene therapy • Cardiovascular diseases
XyloCor Therapeutics develops gene therapies for cardiovascular diseases, focusing on treatments for refractory angina and coronary artery bypass graft surgery.
Maternal health • C-section
Nua Surgical is a maternal health company focused on developing and commercializing the SteriCISION C-Section Retractor to improve outcomes in Caesarean-section surgeries.
Biologics • Therapeutic Antibodies
ATB Therapeutics is a biologics company developing therapeutic antibodies with novel cell-killing mechanisms for oncology and immunology therapies.
Renewable Energy • Infrastructure Modeling
Neara is an AI-powered infrastructure modeling platform that enables utility operators to design efficient networks, manage wildfires and vegetation, expedite renewable projects, and aggregate data into a digital simulation environment, with a focus on overcoming network constraints to the energy transition.
Medical Device • Cardiac Imaging
LUMA Vision is a medical device company specializing in the development of a 4D cardiac imaging and navigation platform called VERAFEYE, currently raising funds to secure FDA approval and commercialize in the U.S. market.
Biotechnology • IPS-T cell therapy
Shinobi Therapeutics is a biotech company developing off-the-shelf, immune-evasive, induced pluripotent stem cell (iPSC)-derived cell therapies for GPC3+ solid tumor cancers.
Travel Services Platform • Experience Curation
Klook is a travel services platform that curates experiences and services across global destinations, focusing on product innovation, expanding city pass offerings, and integrating AI to enhance its marketing and operational efficiency.
Biotech • Alzheimer's Disease Treatment
AstronauTx is a London-based biotech company that develops small-molecule drugs for the treatment of Alzheimer's disease, and has raised £48 million ($61 million) in Series A financing to advance its drug portfolio, including conducting a clinical study for its lead program.